Literature DB >> 23625981

Cigarette smoking has a dose-dependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort (GESPIC).

Denis Poddubnyy, Hildrun Haibel, Joachim Listing, Elisabeth Märker-Hermann, Henning Zeidler, Jürgen Braun, Joachim Sieper, Martin Rudwaleit.   

Abstract

Entities:  

Keywords:  Ankylosing Spondylitis; Smoking; Spondyloarthritis

Mesh：

Year:  2013        PMID： 23625981     DOI： 10.1136/annrheumdis-2012-203148

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  25 in total

1.  Smoking and spondyloarthritis: a bad connection.

Authors:  Daniel Wendling; Clément Prati
Journal:  Rheumatol Int       Date:  2015-10-13       Impact factor: 2.631

Review 2.  Syndesmophyte growth in ankylosing spondylitis.

Authors:  Sovira Tan; Runsheng Wang; Michael M Ward
Journal:  Curr Opin Rheumatol       Date:  2015-07       Impact factor: 5.006

3.  The effect of smoking on clinical and radiographic variables, and acute phase reactants in patients with ankylosing spondylitis.

Authors:  Grigorios T Sakellariou; Athanasios D Anastasilakis; Eustathios Kenanidis; Michael Potoupnis; Eleftherios Tsiridis; Matthaios Savvidis; Nikolaos Kartalis; Fares E Sayegh
Journal:  Rheumatol Int       Date:  2015-10-16       Impact factor: 2.631

4.  Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27.

Authors:  Heidi Lausten Munk; Natasja Staehr Gudmann; Anne Friesgaard Christensen; Leif Ejstrup; Grith Lykke Sorensen; Anne Gitte Loft; Anne C Bay-Jensen; Anne Sofie Siebuhr; Peter Junker
Journal:  Rheumatol Int       Date:  2015-11-30       Impact factor: 2.631

Review 5.  [Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark].

Authors:  T Häupl; A Skapenko; B Hoppe; K Skriner; H Burkhardt; D Poddubnyy; S Ohrndorf; P Sewerin; U Mansmann; B Stuhlmüller; H Schulze-Koops; G-R Burmester
Journal:  Z Rheumatol       Date:  2018-05       Impact factor: 1.372

6.  The role of smoking in the development and progression of structural damage in axial SpA patients: A systematic review and meta-analysis.

Authors:  Servet Akar; Yusuf Cem Kaplan; Sertaç Ecemiş; Elif Keskin-Arslan; Önay Gercik; Sercan Gücenmez; Dilek Solmaz
Journal:  Eur J Rheumatol       Date:  2018-10-01

7.  The prevalence of comorbidity and predictors in ankylosing spondylitis.

Authors:  Gökşen Gökşenoğlu; Derya Buğdaycı; Nurdan Paker; Mustafa Aziz Yıldırım; Özlem Etli
Journal:  Turk J Phys Med Rehabil       Date:  2018-08-21

8.  Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study.

Authors:  Maxime Dougados; Emily Wood; Bernard Combe; Thierry Schaeverbeke; Corinne Miceli-Richard; Francis Berenbaum; Nandan Koppiker; Arnaud Dubanchet; Isabelle Logeart
Journal:  Arthritis Res Ther       Date:  2014-11-27       Impact factor: 5.156

9.  Predictive value of C-reactive protein for radiographic spinal progression in axial spondyloarthritis in dependence on genetic determinants of fibrin clot formation and fibrinolysis.

Authors:  Berthold Hoppe; Christian Schwedler; Hildrun Haibel; Maryna Verba; Fabian Proft; Mikhail Protopopov; Hans-Gert Heuft; Valeria Rios Rodriguez; Anke Edelmann; Martin Rudwaleit; Joachim Sieper; Denis Poddubnyy
Journal:  RMD Open       Date:  2021-06

Review 10.  Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences?

Authors:  X Baraliakos; J Braun
Journal:  RMD Open       Date:  2015-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.